Your browser doesn't support javascript.
loading
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.
Nanishi, Etsuro; Nishio, Hisanori; Takada, Hidetoshi; Yamamura, Kenichiro; Fukazawa, Mitsuharu; Furuno, Kenji; Mizuno, Yumi; Saigo, Kenjiro; Kadoya, Ryo; Ohbuchi, Noriko; Onoe, Yasuhiro; Yamashita, Hironori; Nakayama, Hideki; Hara, Takuya; Ohno, Takuro; Takahashi, Yasuhiko; Hatae, Ken; Harada, Tatsuo; Shimose, Takayuki; Kishimoto, Junji; Ohga, Shouichi; Hara, Toshiro.
Afiliación
  • Nanishi E; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Nishio H; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan hnishio@pediatr.med.kyushu-u.ac.jp.
  • Takada H; Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.
  • Yamamura K; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Fukazawa M; Department of Perinatal and Pediatric Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Furuno K; Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Mizuno Y; Kawasaki Disease Center, Fukuoka Children's Hospital, Fukuoka, Japan.
  • Saigo K; Kawasaki Disease Center, Fukuoka Children's Hospital, Fukuoka, Japan.
  • Kadoya R; Kawasaki Disease Center, Fukuoka Children's Hospital, Fukuoka, Japan.
  • Ohbuchi N; Department of Pediatrics, Yamaguchi Red Cross Hospital, Yamaguchi, Japan.
  • Onoe Y; Department of Pediatrics, Yamaguchi Red Cross Hospital, Yamaguchi, Japan.
  • Yamashita H; Department of Pediatrics, Yamaguchi Red Cross Hospital, Yamaguchi, Japan.
  • Nakayama H; Department of Pediatrics, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.
  • Hara T; Department of Pediatrics, National Hospital Organization Kokura Medical Center, Kitakyushu, Japan.
  • Ohno T; Department of Pediatrics, Fukuoka Higashi Medical Center, Koga, Japan.
  • Takahashi Y; Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan.
  • Hatae K; Department of Pediatrics, Oita Prefectural Hospital, Oita, Japan.
  • Harada T; Department of Pediatrics, Japan Community Healthcare Organization (JCHO) Kyushu Hospital, Kitakyushu, Japan.
  • Shimose T; Department of Pediatrics, Fukuoka Red Cross Hospital, Fukuoka, Japan.
  • Kishimoto J; Department of Pediatrics, Fukuoka Red Cross Hospital, Fukuoka, Japan.
  • Ohga S; Clinical Research Support Center Kyushu, Fukuoka, Japan.
  • Hara T; Department of Research and Development of Next Generation Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Am Heart Assoc ; 6(7)2017 Jul 06.
Article en En | MEDLINE | ID: mdl-28684643
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulinas Intravenosas / Claritromicina / Factores Inmunológicos / Antibacterianos / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Am Heart Assoc Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulinas Intravenosas / Claritromicina / Factores Inmunológicos / Antibacterianos / Síndrome Mucocutáneo Linfonodular Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: Asia Idioma: En Revista: J Am Heart Assoc Año: 2017 Tipo del documento: Article País de afiliación: Japón